98%
921
2 minutes
20
Introduction/objectives: Seizures are common postoperative complications for patients who have undergone surgical management for traumatic brain injury (TBI). However, little is known regarding preoperative factors that predict them. This study aims to describe preoperative factors that influence the occurrence of seizures after surgery for TBI.
Methods: A retrospective study of all operative TBI patients between 2012 and 2021 was performed. Individuals with TBI that received medical management only were excluded. The presence of postoperative seizures was determined according to documentation in the medical record of seizures after the date of surgery for TBI. Individuals who had documented seizures pre-TBI were excluded from the analysis. Univariate comparisons and multivariate logistic regression were performed.
Results: 200 individuals were included in this study. Forty-six individuals (24.96 %) experienced at least one documented postoperative seizure within one week of surgery. Of those, 97.5 % were on Levetiracetam prophylactic coverage. Factors associated with postoperative seizures included age ≥ 60 years (p = .045) and smoking history (p = .048). A trend towards significance was seen in individuals whose injuries included subdural hematomas (p = .086), as well as those with a history of diabetes (p = .053). There were no differences according to initial GCS at presentation (p = .54), presence of EDH (p = .83), IPH (p = .75), SAH/IVH (p = .51), midline shift (p = .114), procedure type (p = .52) (craniotomy or craniectomy). SDH presence (OR 4.39 CI95 % 1.33 - 14.50) and former smoking status (OR 3.49 CI95 % 1.31 - 9.16) were significant risk factors on multivariate analysis when controlling for age, diabetes, and current smoking history. Former smoking remained significant in patients experiencing siezures greater than 7 days post-surgery as well (OR 4.56; CI 95 % 1.13-18.27).
Conclusion: In postoperative TBI patients, former smokers and the presence of SDH significantly increase the risk of experiencing seizures even while on prophylactic ASMs. These factors should be considered when managing postoperative TBI patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clineuro.2025.109116 | DOI Listing |
Radiol Phys Technol
September 2025
Division of Medical Physics, Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, 110085, India.
This study compares the dosimetric performance of Base Dose Optimization (BDO) and Gradient-Based Optimization (GBO) for extended target volumes in Total Body Irradiation (TBI). The focus is on overlapping regions using the Rando Phantom. The study evaluates dose distribution, conformity, homogeneity, and sensitivity to positional deviations.
View Article and Find Full Text PDFJ Neurol Sci
September 2025
Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America.
Background: A key limitation of the IMPACT model for prognostication after severe traumatic brain injury (TBI) is the use of predictors from hospital admission only. We sought to identify if including daily blood labs (e.g.
View Article and Find Full Text PDFClin Neurol Neurosurg
September 2025
Department of Endocrinology, Mymensingh Medical College, Mymensingh 2200, Bangladesh.
Introduction: India experiences the highest number of road traffic fatalities globally. Acquired hypopituitarism is a common sequela in patients who sustain traumatic brain injury (TBI). This study aimed to investigate the prevalence and imaging characteristics of hypopituitarism in patients with TBI at a tertiary care centre in North India.
View Article and Find Full Text PDFNeurology
September 2025
Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Charlestown, MA.
Background And Objectives: Moderate-to-severe traumatic brain injury (TBI) can result in disability across physical, social, and cognitive domains. The Glasgow Outcome Scale-Extended (GOSE), which evaluates global function, is the most frequently used TBI outcome measure. However, the GOSE may not capture all domains of recovery.
View Article and Find Full Text PDFCrit Care Explor
September 2025
Surgical Services, Minneapolis VA Medical Center, Minneapolis, MN.
Objective: This post hoc study of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III trial investigates whether improving traumatic brain injury (TBI) classification, using serum biomarkers (glial fibrillary acidic protein [GFAP] and ubiquitin carboxyl-terminal esterase L1 [UCH-L1]) and algorithmically assessed total lesion volume, could identify a subset of responders to progesterone treatment, beyond broad measures like the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale-Extended (GOS-E), which may fail to capture subtle changes in TBI recovery.
Design: Brain lesion volumes on CT scans were quantified using Brain Lesion Analysis and Segmentation Tool for CT. Patients were classified into true-positive and true-negative groups based on an optimization scheme to determine a threshold that maximizes agreement between radiological assessment and objectively measured lesion volume.